[{"id":"a6d31f53-b654-4da8-90c1-1275e4f0fcec","acronym":"","url":"https://clinicaltrials.gov/study/NCT04485949","created_at":"2024-03-05T19:33:23.646Z","updated_at":"2024-07-02T16:34:59.826Z","phase":"Phase 2","brief_title":"A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma","source_id_and_acronym":"NCT04485949","lead_sponsor":"Imvax","biomarkers":" MGMT","pipe":"","alterations":" ","tags":["MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide • IGV-001"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 93","initiation":"Initiation: 03/20/2023","start_date":" 03/20/2023","primary_txt":" Primary completion: 01/01/2025","primary_completion_date":" 01/01/2025","study_txt":" Completion: 07/01/2027","study_completion_date":" 07/01/2027","last_update_posted":"2024-05-31"}]